This image provided by Guardant Health in March 13, 2024, shows a vial for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the New England Journal of Medicine and sponsored by Guardant Health, the test performed well, further expanding screening options for a leading cause of cancer deaths. The test missed some cancers and won’t replace colonoscopy, the gold standard test. (Guardant Health via AP)
This image provided by Guardant Health in March 2024, shows packaging for their colon cancer blood test, Shield. According to a study published Wednesday, March 13, 2024, in the New England Journal of Medicine and sponsored by Guardant Health, the test performed well, further expanding screening options for a leading cause of cancer deaths. The test missed some cancers and won’t replace colonoscopy, the gold standard test. (Guardant Health via AP)